No Selling, Just Helping: Inside Bullpen’s Vision for the CGT Movement
By Sofia Prado-Irwin, PhD
Christiaan Engstrom is CEO and Co-founder of the Bullpen, an invite-only, volunteer-led club that gathers Life Science Investors and CxOs with a shared goal of helping each other. Christiaan …
Bringing Cell Therapies Closer to Patients with Innovative Manufacturing
By Sofia Prado-Irwin, PhD
Lars Peeck, PhD is the Chief Business Officer at Astraveus, whose flagship product—the Lakhesys™ Benchtop Cell Factory™—is revolutionizing Cell and Gene Therapy (CGT) manufacturing. A …
Leading with Patient and Purpose in CGT
By Sofia Prado-Irwin, PhD
Dr. Timothy Fong is an accomplished scientist and experienced R&D leader with demonstrated scientific and business skills in the biotechnology industry. He holds a PhD in Immunology from …
Driving CGT Innovation by Building More Metabolically Fit Cells
By Sofia Prado-Irwin, PhD
Dr. Shannon Eaker, Chief Technology Officer at Xcell Biosciences, is a veteran CGT scientist with deep expertise in T-cell, HSC, and ES/iPSC biology. He serves on the ISCT Process Development and …
Belief Drives Success and Teams Make It Possible
By Sofia Prado-Irwin, PhD
Dr. Miguel Forte’s illustrious career spans decades of work in medicine, academia, regulation, and business. He has held countless leadership positions, including top executive roles at …
Building Ecosystems and Inspiring Leaders in Cell and Gene Therapy
By Sofia Prado-Irwin, PhD
Dr. Uma Lakshmipathy is an acclaimed scientist and strategist with 20+ years of experience in cell biology, stem cells, translational research and cell therapy. A leader in research and …